Effect of sodium-glucose co-transporter-2 inhibitors on coronary blood flow in patients with type 2 diabetes mellitus

CONCLUSIONS: We have demonstrated that the use of SGLT-2is improves coronary artery blood flow in patients with T2DM who have normal or nearly normal coronary angiography.PMID:37667939 | DOI:10.26355/eurrev_202308_33414

Source: Pharmacological Reviews - September 5, 2023 Category: Drugs & Pharmacology Authors: E Ta ştan S S öner A D C ömert M Altunba ş R T üzün C Öztürk A Aky üz F I şık M Çap Ö Bilge M S üleymanoğlu M Ok şul Source Type: research